Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
PURE BIOSCIENCE Add to My Watchlist (NSDQ: PURE) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     PURE Bioscienc 1.29 - (+0.00%) 51,396
1725 Gillespie Way
El Cajon, CA 92020 US
(619) 596-8600
(619) 596-8791 fax
www.purebio.com
CEO Michael L. Krall
Auditor Mayer Hoffman McCann P.C.
Exchange Traded NQ
ISIN Number US7462181063
CIK Number 1006028
NAICS Code 333319
Business Summary
The Company is developing technology-based bioscience products, including its silver dihydrogen citrate-based antimicrobials, non-toxic solutions to numerous global health challenges and represent innovative advances in diverse markets.
Number of Employees 23
Share Fundamentals
Market Cap 44.29M
Shares Outstanding 34.33M
Float 31.48M
Short Interest 523.29K
Financial Strength
Revenue (TTM) $839,871
Earnings (TTM) -$7,173,195
Quick Ratio 10:1
Current Ratio 10.8:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs